Preferential Hematopoietic Differentiation in Induced Pluripotent Stem Cells Derived From Human Umbilical Cord Arterial Endothelial Cells
Arteriosclerosis, Thrombosis, and Vascular Biology · 2023-05 · 43 (5) · 697-712
DOI: 10.1161/atvbaha.122.318723 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2023-05. Verfasst von Haiyun Pei und 14 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Hematology and Biochemistry Laboratory, Beijing Institute of Radiation Medicine, China (H.P.). Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Pluripotent Stem Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben.
Abstract (Originalsprache)
Background
The major obstacle for applications of human induced pluripotent stem cells (hiPSCs) is efficient and controlled lineage-specific differentiation. Hence, a deeper understanding of the initial populations of hiPSCs is required to instruct proficient lineage commitment. Methods: hiPSCs were generated from somatic cells by transduction of 4 human transcription factors (OCT4, SOX2, KLF4, and C-MYC) using Sendai virus vectors. Genome-wide DNA methylation analysis and transcriptional analysis were performed to evaluate the pluripotent capacity and somatic memory state of hiPSCs. Flow cytometric analysis and colony assays were performed to assess the hematopoietic differentiation capacity of hiPSCs.
Results
Here, we reveal human umbilical arterial endothelial cell–derived induced pluripotent stem cells (HuA-iPSCs) exhibit indistinguishable pluripotency in comparison with human embryonic stem cells and hiPSCs derived from other tissues of origin (umbilical vein endothelial cells, cord blood, foreskin fibroblasts, and fetal skin fibroblasts). However, HuA-iPSCs retain a transcriptional memory typical of the parental human umbilical cord arterial endothelial cells, together with a strikingly similar DNA methylation signature to umbilical cord blood–derived induced pluripotent stem cells that distinguishes them from other human pluripotent stem cells. Ultimately, HuA-iPSCs are most efficient in targeted differentiation toward hematopoietic lineage among all human pluripotent stem cells based on the functional and quantitative evaluation of both flow cytometric analysis and colony assays. Application of the Rho-kinase activator significantly reduces the effects of preferential hematopoietic differentiation in HuA-iPSCs, reflected in CD34 + cell percentage of day 7, hematopoietic/endothelial-associated gene expression, and even colony-forming unit numbers.
Conclusions
Collectively, our data suggest that somatic cell memory may predispose HuA-iPSCs to differentiate more amenably into hematopoietic fate, bringing us closer to generating hematopoietic cell types in vitro from nonhematopoietic tissue for therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Experimental Hematology and Biochemistry Laboratory, Beijing Institute of Radiation Medicine, China (H.P.).
- South China Research Center for Stem Cell and Regenerative Medicine, SCIB, Guangzhou (H.P., B.Z., Y.J., X.X., L.H., W.Y., X.P.).
- Institute of Health Service and Transfusion Medicine, Beijing, China (H.L., Z.Y., L.H.).
- Stem Cell and Regenerative Medicine Laboratory, Beijing Institute of Radiation Medicine, China (L.X., B.Z., Y.J., L.L., X.X., Z.F., X.W., F.S., W.Y., X.P.).
- Department of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (H.Z.).
ORCID-Profile: Haiyun Pei, Huilin Li, Lei Xu, Yali Jia, Xiaoyan Xie, Xiaoling Wang, Wen Yue, Xuetao Pei
Zitieren
APA
Pei, H., Li, H., Xu, L., Zhang, B., Zhang, H., Jia, Y., Liang, L., Xie, X., Fan, Z., Yang, Z., Wang, X., Song, F., He, L., Yue, W., & Pei, X. (2023). Preferential Hematopoietic Differentiation in Induced Pluripotent Stem Cells Derived From Human Umbilical Cord Arterial Endothelial Cells. Arteriosclerosis, Thrombosis, and Vascular Biology, 43(5), 697-712. https://doi.org/10.1161/atvbaha.122.318723
Vancouver
Pei H, Li H, Xu L, Zhang B, Zhang H, Jia Y, et al. Preferential Hematopoietic Differentiation in Induced Pluripotent Stem Cells Derived From Human Umbilical Cord Arterial Endothelial Cells. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023;43(5):697-712. doi:10.1161/atvbaha.122.318723
BibTeX
@article{Pei2023,
author = {Pei, Haiyun and Li, Huilin and Xu, Lei and Zhang, Bowen and Zhang, Heng and Jia, Yali and Liang, Liqing and Xie, Xiaoyan and Fan, Zeng and Yang, Zhou and Wang, Xiaoling and Song, Feiling and He, Lijuan and Yue, Wen and Pei, Xuetao},
title = {Preferential Hematopoietic Differentiation in Induced Pluripotent Stem Cells Derived From Human Umbilical Cord Arterial Endothelial Cells},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2023},
volume = {43},
number = {5},
pages = {697--712},
doi = {10.1161/atvbaha.122.318723}
}
EUVIMED